About OKRA
OKRA is a company based in Cambridge (United Kingdom) founded in 2016 by Loubna Bouarfa was acquired by Envision Pharma Group in February 2023. OKRA has raised $4.16 million across 1 funding round from investors including Envision Pharma Group. The company has 22 employees as of December 31, 2019. OKRA offers products and services including AI Brain, Commercial Solutions, and Medical Intelligence. OKRA operates in a competitive market with competitors including IQVIA, AVIA, Dental Intel, Hublo and Advisory, among others.
- Headquarter Cambridge, United Kingdom
- Employees 22 as on 31 Dec, 2019
- Founders Loubna Bouarfa
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Okra Technologies Limited
- Date of Incorporation 14 Jul, 2015
- Jurisdiction HORSHAM, WEST SUSSEX, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.16 M (USD)
in 1 rounds
-
Latest Funding Round
$4.16 M (USD), Series A
Mar 01, 2018
- Investors
-
Employee Count
22
as on Dec 31, 2019
-
Acquired by
Envision Pharma Group
(Feb 07, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OKRA
OKRA offers a comprehensive portfolio of products and services, including AI Brain, Commercial Solutions, and Medical Intelligence.
Delivers insights for life sciences decision-making and data analysis.
Optimizes HCP interactions with detailed priority insights.
Analyzes trends and unmet needs in medical affairs.
People of OKRA
Unlock access to complete
Funding Insights of OKRA
OKRA has successfully raised a total of $4.16M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.16 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OKRA
OKRA has secured backing from 1 investor. Prominent investors backing the company include Envision Pharma Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Compliant global publication planning is offered for life sciences.
|
Locked | Locked | Locked |
Investor details for OKRA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OKRA
Investment portfolio details for OKRA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OKRA
Detailed financials for OKRA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Okra Comparisons
Peer comparison for OKRA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OKRA
OKRA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IQVIA, AVIA, Dental Intel, Hublo and Advisory, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical research and commercialization solutions are provided for healthcare.
|
|
| Locked | Locked | Locked |
Digital platform for healthcare management and networking is offered.
|
|
| Locked | Locked | Locked |
Dental intelligence is delivered via SaaS platform for performance analytics.
|
|
| Locked | Locked | Locked |
Platform for hospitals to manage staff recruitments and replacements
|
|
| Locked | Locked | Locked |
Analytics platforms and consulting services for business intelligence are offered.
|
|
| Locked | Locked | Locked |
A real-time care orchestration platform for healthcare systems is provided by DexCare.
|
Detailed competitors of OKRA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Okra
Complete news archive for OKRA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OKRA
OKRA was founded in 2016 and raised its 1st funding round 2 years after it was founded.
OKRA is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Loubna Bouarfa is the current CEO of OKRA. They have also founded this company.
OKRA is a funded company, having raised a total of $4.16M across 1 funding round to date.
As of Dec 31, 2019, the latest employee count at OKRA is 22.
AI powered platform specializing in healthcare and life sciences. It integrates and analyzes complex datasets from internal, public, and third-party sources to deliver actionable, evidence-based insights and predictions in real time. The platform supports decision-making across the drug development and commercialization lifecycle, helping pharmaceutical and life sciences professionals optimize commercial, medical, and market access strategies.
OKRA offers AI Brain, Commercial Solutions, and Medical Intelligence.
OKRA has 1 investor. Key investors include Envision Pharma Group.